HGS v. Eli Lilly, UK Supreme Court, 2 November 2011
The UK Supreme Court overturned the decision of the High Court and the Court of Appeal that HGS’s patent directed towards Neutrokine, a new protein and member of the ligand superfamily, lacked industrial applicability. Click here for the full text of this case. A summary of this case will be posted on http://www.KluwerIPCases.com.